Research location
Bensalem
Pennsylvania, United States
Advertisement
Research activity in Bensalem
Pennsylvania, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 53 trials and 54 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Bensalem
53 linked trials · page 1 of 2A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)NCT07144280 · 2025-09-29 · 1 site observation
RECRUITING
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast CancerNCT05748834 · 2023-07-24 · 1 site observation
RECRUITING
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast CancerNCT06966453 · 2025-06-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung CancerNCT06012435 · 2024-02-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)NCT06065748 · 2023-12-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2NCT05438498 · 2022-06-03 · 1 site observation
TERMINATED
Breast Cancer Index (BCI) RegistryNCT04875351 · 2021-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.NCT01966107 · 2013-10-16 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · 2012-06-01 · 1 site observation
TERMINATED
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 HypertensionNCT01508026 · 2012-01-01 · 2 site observations
COMPLETED
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.NCT01475721 · 2011-11-18 · 1 site observation
COMPLETED
Radiation Therapy in Treating Patients With Prostate CancerNCT01434290 · 2011-09-01 · 1 site observation
COMPLETED
Pharmacokinetics/Pharmacodynamics of AlbiglutideNCT01357889 · 2011-07-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)NCT01137812 · 2010-07-01 · 1 site observation
COMPLETED
The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)NCT01106690 · 2010-06-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneNCT01089790 · 2010-03-01 · 1 site observation
TERMINATED
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.NCT01033071 · 2010-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesNCT01023581 · 2009-11-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineNCT00976391 · 2009-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe HypertensionNCT00846365 · 2009-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesNCT00838903 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 DiabetesNCT00838916 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesNCT00839527 · 2009-02-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Albiglutide in Type 2 DiabetesNCT00849017 · 2009-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of Albiglutide in Type 2 DiabetesNCT00849056 · 2009-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionNCT00847626 · 2009-01-01 · 1 site observation
COMPLETED
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.NCT00755287 · 2008-11-01 · 1 site observation
COMPLETED
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.NCT00744367 · 2008-10-01 · 1 site observation
COMPLETED
A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or ThiazolidinedioneNCT00743002 · 2008-08-01 · 1 site observation
COMPLETED
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese SubjectsNCT00788528 · 2008-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsNCT00707993 · 2008-06-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionNCT00649389 · 2008-05-01 · 1 site observation
COMPLETED
Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast AbnormalitiesNCT00606931 · 2008-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential HypertensionNCT00591773 · 2007-09-01 · 1 site observation
COMPLETED
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie DietNCT00748605 · 2007-06-01 · 1 site observation
COMPLETED
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin OnlyNCT00518115 · 2007-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes MellitusNCT00760344 · 2007-03-01 · 1 site observation
COMPLETED
A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult SubjectsNCT00449501 · 2007-03-01 · 1 site observation
COMPLETED
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra RiskNCT00412113 · 2007-01-01 · 1 site observation
COMPLETED
A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDNCT00419744 · 2007-01-01 · 1 site observation
COMPLETED
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 DiabetesNCT00411892 · 2006-11-29 · 1 site observation
TERMINATED
Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 DiabetesNCT00348374 · 2006-06-01 · 1 site observation
COMPLETED
Caduet in an Untreated Subject PopulationNCT00332761 · 2006-06-01 · 1 site observation
COMPLETED
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-upNCT00309244 · 2006-02-01 · 1 site observation
COMPLETED
Efficacy & Safety of Inhaled Insulin in Type 1 DiabetesNCT00308308 · 2006-02-01 · 1 site observation
COMPLETED
Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917NCT00290940 · 2006-01-01 · 1 site observation
COMPLETED
A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusNCT00263276 · 2005-12-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic NeuropathyNCT00113620 · 2005-07-01 · 1 site observation
COMPLETED
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionNCT00185133 · 2005-05-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.